|

Rural Community Peer Partnerships for Improving Methamphetamine-Associated Heart Failure Screening and Engagement

RECRUITINGN/ASponsored by Oregon Health and Science University
Actively Recruiting
PhaseN/A
SponsorOregon Health and Science University
Started2024-08-19
Est. completion2029-06-30
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT06461962

Summary

The goal of PEER-Heart is to implement and assess feasibility and preliminary effectiveness of a community peer-facilitated screening for methamphetamine-associated heart failure (MAHF) and linkage to evidence-based cardiology care for people who use methamphetamine in rural areas.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Patient-defined regular use of methamphetamine in the last year
* Any methamphetamine use in the past 30 days
* Age 18 years or older
* No client-reported diagnosis of heart failure
* Able to communicate in English
* Screen positive for potential methamphetamine-associated heart failure (MAHF) defined as B type natriuretic peptide (BNP) ≥50 pg/ml, or QRS width ≥120ms, or presence of any clinical heart failure symptoms

Exclusion Criteria:

* Self-reported engagement in medical care for heart failure in past 6 months.
* Actively taking medications for heart failure.

Conditions3

Heart DiseaseHeart FailureMethamphetamine Use

Locations1 site

Oregon Health & Science University
Portland, Oregon, 97239
Brian Chan, MD, MPH503-494-2010chanbri@ohsu.edu

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.